Manulife Financial Corporation vs Northrop Grumman Corporation — how do they compare? Manulife Financial Corporation trades at $42.74 (market cap $69.96B), while Northrop Grumman Corporation trades at $509.08 (market cap $74.42B). The key difference: Manulife Financial Corporation and Northrop Grumman Corporation are close in size by market cap, and Manulife Financial Corporation pays the higher dividend (3.14%). Which is the better fit depends on your goals.
| MFC | NOC | |
|---|---|---|
Market Cap | $69.96B | $74.42B |
Sector | Financials | Industrials |
52-Week High | $43.39 | $768.02 |
52-Week Low | $29.90 | $496.02 |
Enterprise Value | $66.52B | $88.65B |
Dividend Yield | 3.14% | 1.79% |
Signals from Pluang's Aura AI — not financial advice
Manulife Financial (MFC) trades at $42.56, down 1.91% today but remains near 52-week highs. The stock shows strong fundamentals with revenue growth from $46.2B in 2024 to $53.0B in 2025 and consistent profitability (12.07% net margin). Technical indicators are mixed with bullish moving averages but overbought RSI levels. Recent Q1 2026 earnings missed expectations despite strong Asia performance, while analyst consensus remains bullish with 57% buy ratings.
MFC presents a compelling value case with reasonable valuation (P/E 17.75) and dividend yield support. Key opportunities include AI integration partnerships and Asia growth, though risks include wealth management outflows and regulatory scrutiny. The stock's current technical overbought condition suggests potential near-term consolidation before resuming upward trajectory.
Northrop Grumman (NOC) trades at $524.14, up 0.49% with a bearish technical signal despite strong fundamentals. The company shows consistent earnings beats, with Q1 2026 EPS of $6.14 exceeding expectations of $6.06. Recent news highlights defense budget optimism and a $312.3M Navy contract for electronic warfare systems. Technical indicators show RSI at oversold levels near support at $518, while moving averages signal bearish momentum.
The investment outlook remains positive with analyst consensus at Buy (57% of 35 analysts) and a $655 price target representing 25% upside. Risks include execution challenges in defense programs and potential margin pressure. Strong cash flow generation and a $96B backlog support long-term growth, though near-term technical weakness may present entry opportunities for patient investors.
Trailing returns across standard periods
Latest headlines on both assets
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →